For health professionals: Rotavirus
Find detailed information on rotavirus for health professionals.
On this page
- What health professionals need to know about rotavirus
- Clinical manifestations
- Prevention and control
- For more information
What health professionals need to know about rotavirus
Rotavirus has a double stranded RNA genome composed of 11 segments contained within 3 concentric shells. The outermost shell is composed of 2 proteins:
- VP4 (P Protein)
- VP7 (G Protein)
These proteins are important for vaccine development and immune response. The prevalence of rotavirus serotypes varies from year to year and by region.
However, G1P has been detected consistently and is often the predominant strain in developed regions.
Rotavirus infections can be asymptomatic or present with mild to severe symptoms. In some cases, infection can lead to severe dehydration and death.
Severity of infection is age-dependent, with clinically significant disease occurring most frequently in infants and young children. In Canada, healthy children experience self-limiting illness, rarely resulting in long-term sequelae.
Following a 1 to 3 day incubation period, cases develop fever, diarrhea and vomiting, either alone or in combination.
Rotavirus infections can cause:
- electrolyte imbalance
- mild to severe dehydration
- secondary disaccharidase deficiency (in prolonged cases)
Subsequent rotavirus infections tend to be less severe compared to the first infection with the virus. Temporal associations of rotavirus infection with a variety of disease conditions have been described, including upper and lower respiratory infection.
Prevention and control
For information on vaccination, please consult the section in the Canadian Immunization Guide on rotavirus vaccine.
Laboratory testing for rotavirus is not routinely done. Clinical symptoms are more often used to identify infection.
The most commonly used method to confirm a rotavirus infection is detection of the rotavirus antigen through enzyme-linked immunoassay.
Rotavirus infections are self-limiting in people with healthy immune systems. The disease usually lasts a few days.
Treatment consists primarily of oral rehydration therapy to prevent dehydration. The resumption of a normal diet should be promoted after rehydration.
Health professionals in Canada play a critical role in identifying and reporting cases of rotavirus. See the surveillance section for more information on surveillance in Canada.
For more information
- Canadian Immunization Guide: Rotavirus vaccine
- Human rotavirus: Pathogen safety data sheet – Infectious substances
- Canada Communicable Disease Report
- Listing of therapeutic products with pediatric information available in their labelling
Report a problem or mistake on this page
- Date modified: